Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DV.7.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDHEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.367EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.385EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.244EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.17.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.7.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.10.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KG.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.351 (Beta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.19.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.100EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.43.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EU.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.8ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-19262.2China
JL.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-19262.8Japan
HZ.1SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-19262.8Japan
BA.2.7ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-19265.7Germany
GJ.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19280Singapore
FL.32.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19280Singapore
BL.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19280Singapore
KP.3.2.5ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-19293.4Japan
BN.1.1.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-19294.3Thailand
B.1.1.227SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-19301.9Japan
B.1.619SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-19302.9Japan
B.1.619.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-19302.9Japan
BN.3.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-19313.7China
BN.3ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-19313.7China
XBRORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-19313.7China
AY.47 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-19324.2Thailand
A.7NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-19324.2Thailand
B.1.367ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-19336.4Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used